DNA damage signaling in oxygen toxicity in lung cells
肺细胞氧毒性中的 DNA 损伤信号传导
基本信息
- 批准号:7188661
- 负责人:
- 金额:$ 26.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAdultAffectApoptosisAtaxiaBiological AssayCaringCell Cycle ProgressionCellsCheckpoint kinase 1ClinicalComplexDNADNA DamageDominant-Negative MutationExposure toGeneticHydrogen PeroxideHyperoxiaInfantIonizing radiationLightLungMediatingMitosisMolecularMutagensNatureNumbersOxidantsOxygenOxygen Therapy CarePathway interactionsPeroxidesPhase TransitionPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPlayProtein FamilyProtein p53ProteinsReactive Oxygen SpeciesResearch PersonnelRespiratory FailureRespiratory InsufficiencyRoleSerineSignal TransductionSignal Transduction PathwayStimulusTP53 geneTestingTransducersataxia telangiectasia mutated proteincell injurygenetic inhibitorimprovedinhibitor/antagonistinterestmemberoxygen toxicitypreventprogramsrepairedresearch studyresponsesensor
项目摘要
DESCRIPTION (provided by applicant): Hyperoxia is known to produce elevated levels of reactive oxygen species (ROS) that can damage DNA. The cellular response to DNA damage is complex and involves gene-products that recognize DNA damage and transduce the signal to various sensors, which, in turn, inhibit proliferation, stimulate repair or induce apoptosis. Although the DNA damage response induced by oxidants such as hydrogen peroxide (H202) or other peroxides have been studied, less is known about how cells respond to DNA damage in hyperoxia. Elucidating how lung cells respond to hyperoxic DNA damage is critical for understanding pulmonary oxygen toxicity. ATM (ataxia telangiecea) and ATR (ATM-Rad3-related) are members of the phosphatidylinositol 3-kinase-related kinases (PIKK) family of proteins that have been shown to transduce DNA damage signals in response to exposure to genotoxic agents. The experiments proposed here test the hypothesis that ATR transduces hyperoxia-mediated DNA damage signals by activating checkpoint proteins p53 and/or checkpoint kinase1 (Chk1). This results in inactivation of cdc25C, which inhibits cdc2 kinase activity, thereby preventing cell cycle progression. First, we will determine whether ATR is activated in hyperoxia in lung cells. This will be achieved using inhibitors for PIKKs, and by genetic approaches involving dominant-negative constructs of ATR or ATM, and the use of ATM+/+ or ATM-/- cells (Aim 1). Next we will determine the nature of DNA damage induced in hyperoxia and how that differs from H202 or UV (Aim 2). In our next specific aim we will determine whether hyperoxia specifically activates Chk1 directly or in an ATR-dependent manner resulting in cdc25C inactivation. We will use specific inhibitors of Chk1 and genetic approaches to delineate the role of Chk1 and cdc25C in DNA damage signaling in hyperoxia (Aim 3). In our next specific aim (Aim 4) we will determine the mechanisms of inactivation of cdc2 kinase activity. We will use various kinase and phosphatase assays and genetic and inhibitor studies to define the mechanisms of inhibition of cdc2 in hyperoxia. Using these molecular approaches, we will define the mechanisms of DNA damage signaling n hyperoxia, which will significantly improve our understanding of pulmonary oxygen toxicity in lung cells
描述(由申请人提供):已知高氧会产生可损伤DNA的活性氧(ROS)水平升高。细胞对DNA损伤的反应是复杂的,涉及识别DNA损伤并将信号传递给各种传感器的基因产物,这些传感器反过来抑制增殖、刺激修复或诱导凋亡。虽然已经研究了由氧化剂如过氧化氢(H2 O2)或其他过氧化物诱导的DNA损伤反应,但关于细胞如何在高氧下对DNA损伤作出反应的了解较少。阐明肺细胞对高氧DNA损伤的反应对于理解肺氧毒性至关重要。ATM(毛细血管共济失调)和ATR(ATM-Rad 3相关)是磷脂酰肌醇3-激酶相关激酶(PIKK)蛋白家族的成员,已被证明在暴露于遗传毒性物质时会抑制DNA损伤信号。本文提出的实验验证了ATR通过激活检查点蛋白p53和/或检查点激酶1(Chk 1)转导高氧介导的DNA损伤信号的假设。这导致cdc 25 C失活,其抑制cdc 2激酶活性,从而阻止细胞周期进展。首先,我们将确定ATR是否在肺细胞中的高氧中被激活。这将通过使用PIKK抑制剂,并通过涉及ATR或ATM的显性阴性构建体的遗传方法,以及使用ATM+/+或ATM-/-细胞来实现(目的1)。接下来,我们将确定高氧诱导的DNA损伤的性质以及与H2 O2或UV的不同之处(目的2)。在我们的下一个具体目标,我们将确定是否高氧特异性激活Chk 1直接或在ATR依赖的方式导致cdc 25 C失活。我们将使用Chk 1的特异性抑制剂和遗传学方法来描述Chk 1和cdc 25 C在高氧DNA损伤信号传导中的作用(目的3)。在我们的下一个具体目标(目标4)中,我们将确定cdc 2激酶活性失活的机制。我们将使用各种激酶和磷酸酶检测以及遗传和抑制剂研究来确定高氧中cdc 2抑制的机制。利用这些分子生物学方法,我们将确定DNA损伤信号转导机制,这将大大提高我们对肺细胞肺氧毒性的理解
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KUMUDA C DAS其他文献
KUMUDA C DAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KUMUDA C DAS', 18)}}的其他基金
Vascular dysfunction in coronary microcirculation
冠状动脉微循环血管功能障碍
- 批准号:
10539280 - 财政年份:2021
- 资助金额:
$ 26.93万 - 项目类别:
Vascular dysfunction in coronary microcirculation
冠状动脉微循环血管功能障碍
- 批准号:
10361862 - 财政年份:2021
- 资助金额:
$ 26.93万 - 项目类别:
Amelioration and Reversal of Hypertension by Thioredoxin
硫氧还蛋白改善和逆转高血压
- 批准号:
9156261 - 财政年份:2016
- 资助金额:
$ 26.93万 - 项目类别:
Amelioration of Mitochondrial Dysfunction by Thioredoxin in Hyperoxia
高氧状态下硫氧还蛋白改善线粒体功能障碍
- 批准号:
9241419 - 财政年份:2016
- 资助金额:
$ 26.93万 - 项目类别:
Amelioration of Mitochondrial Dysfunction by Thioredoxin in Hyperoxia
高氧状态下硫氧还蛋白改善线粒体功能障碍
- 批准号:
9113702 - 财政年份:2016
- 资助金额:
$ 26.93万 - 项目类别:
Amelioration of Mitochondrial Dysfunction by Thioredoxin in Hyperoxia
高氧状态下硫氧还蛋白改善线粒体功能障碍
- 批准号:
9324635 - 财政年份:2016
- 资助金额:
$ 26.93万 - 项目类别:
Endothelial dysfunction in aged Trx-deficient mice.
老年 Trx 缺陷小鼠的内皮功能障碍。
- 批准号:
8675920 - 财政年份:2011
- 资助金额:
$ 26.93万 - 项目类别:
Endothelial dysfunction in aged Trx-deficient mice.
老年 Trx 缺陷小鼠的内皮功能障碍。
- 批准号:
8851123 - 财政年份:2011
- 资助金额:
$ 26.93万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 26.93万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 26.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 26.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 26.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




